Navigation Links
David Duncan Has a Prescription for American Health Care
Date:9/14/2009

BOSTON, Sept. 14 /PRNewswire/ -- The 13th Annual Scientific Meeting of the Heart Failure Society of America (HFSA) today featured a discussion by David Ewing Duncan titled "One Man's Quest for Personalized Medicine." Over the course of one year, Duncan submitted himself to hundreds of tests that could predict and even prevent future illness.

One test made predictions about the health of Duncan's heart. By gathering data on his cholesterol levels, a heart CT scan, a genetic profile, and more, the test showed personalized predictions that were specific to Duncan's genes and physiology. One scenario showed Duncan's risk of heart attack at 70% over the next twenty years. That forecast changed dramatically if Duncan maintains his current weight instead of gaining the typical pound per year for a man over 40. With a steady weight, the risk fell to about 2 percent and with cholesterol lowering statins, Duncan's risk fell to zero.

"Many of these tests aren't ready for the general public, but they do give us an interesting glimpse into the future of medicine," said Duncan. "People are curious as to where this technology is going and we may never know unless we provide the organized push needed to learn more."

This specific test would cost nearly $1000 as demand increases but Duncan points out that a diagnostic cardiac catheterization can cost more than $25,000 and a heart bypass operation runs well over $85,000. The cost also has to be weighed against the 80 million Americans suffering from heart disease and the fact that nearly $450 billion was spent last year in direct and indirect costs for treatment of heart disease.

"David Duncan's journey through the American Health care system as a healthy person illustrates one of the major problems facing the American health care system today. That is, as health care professionals we recognize that it is imperative to identify p
'/>"/>

SOURCE The Heart Failure Society of America
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Delcath Systems, Inc. Appoints David McDonald Chief Financial Officer
2. David Blumenthal and Aneesh Chopra Give Keynote Addresses at AMIAs Conference on Anticipating and Addressing Unintended Consequences of HIT and Policy
3. Allied Worlds David Bell to Present as Keynote Speaker at 2009 Entrepreneurial Insurance Symposium
4. Pro Quarterback David Garrard Aims to Score Big For Crohns Disease During the 2009 Football Season
5. Health Expert Dr. David Friedman Reveals Which Sweeteners Are Best
6. Dr. David Okrongly Appointed CEO of Quanterix Corporation
7. Jackson & Coker Names David Booher Vice President of Emergency Medicine Recruitment
8. Phoenix Cardiovascular Surgeon, David J. Caparrelli, M.D. Becomes Member of the Society for Vascular Surgery
9. Re-Envision Your Look: Dr. David Whiteman Suggests Breast Revision Surgery as Solution for Women Dissatisfied with Prior Procedures
10. Huntsville, Alabama Plastic Surgeon David L. Durst, MD Comments on Silicone Breast Implants after Nearly 3 Years on the Open Market
11. Dr. David Williams Featured on Searchvitaminsupplements.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... 2015 As the Mayo Clinic's 2012 ... Ford & Associates Nationwide Legal Services, A.P.C., comments on ... lawsuit: Verduzco v. Daiichi Sankyo, Inc., Case No. 3:15-cv-159, ... , “In light of a recently filed lawsuit, Ford ... evaluate and explore the Mayo Clinic's Benicar case study ...
(Date:3/5/2015)... London, UK (PRWEB) March 06, 2015 ... of them being first–in-class. AstraZeneca tops the list scoring ... field obtained over 25% of all FDA approved drug ... total. First-in-class mechanisms such as anti-PCSK9, anti-PD1 and CDK ... have been approved by the FDA to treat metastatic ...
(Date:3/5/2015)... 2015 This week, 60 ... low-cost laminate flooring products, initiating widespread concern from ... building materials made primarily from bamboo, stands behind ... their flooring products for volatile organic compounds (VOCs) ... International (BMH). Results from formaldehyde emissions testing ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 Risperdal ... in a Pennsylvania mass tort litigation currently underway ... a jury has begun hearing testimony in the ... atypical antipsychotic medication can cause gynecomastia, or male ... in question was filed on behalf of a ...
(Date:3/5/2015)... 2015 Rhode Island Medical Imaging (RIMI) was ... row to support the Providence College (PC) women’s basketball program’s ... purchase of the ‘Think Pink’ uniforms, which were worn during ... opponent DePaul University at Alumni Hall/Mullaney Gymnasium in Providence, R.I. ... of the PC women’s basketball’s ‘Pink Out’ event,” said Dr. ...
Breaking Medicine News(10 mins):Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 2Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 3Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 4Health News:World Pharma Business and Large-Cap Companies Discussed by MP Advisors in In-demand Study Available at MarketPublishers.com 2Health News:World Pharma Business and Large-Cap Companies Discussed by MP Advisors in In-demand Study Available at MarketPublishers.com 3Health News:With Homeowners Concerned About Formaldehyde, Cali Bamboo Puts Safety Above Bottom Line 2Health News:Risperdal Lawsuits Move Forward in Pennsylvania, as Bernstein Liebhard LLP Comments on Start of Second Gynecomastia Trial 2Health News:Risperdal Lawsuits Move Forward in Pennsylvania, as Bernstein Liebhard LLP Comments on Start of Second Gynecomastia Trial 3Health News:RIMI Teams Up with PC Women’s Basketball in the Fight Against Breast Cancer 2
... have been hit hard with the government banning the ... foot-and-mouth disease in the kingdom.// ,A Bhutan government ... affects all species of cloven-hoofed animals were being reported ... district, bordering India's northeastern state of Assam. ,"The ...
... tumor which is found resistant to most of the ... The main causative agents for the development of Malignant ... virus 40 (SV40) is also found to be a ... people with malignant mesothelioma have worked or lived in ...
... born at night have an increased risk of death, by ... times of the day said a new research published in ... ,Researchers for Division of Neonatal and Developmental Medicine, Stanford University, ... more for babies in their first month of life than ...
... Saturday administered a "defeat AIDS pledge"// to people in ... ,India has 5.13 million people infected with HIV/AIDS. Andhra ... the country with more than 400,000 affected people. According ... prevalence rate is an alarmingly 2.25 percent among antenatal ...
... affecting the left-brain than the right brain, said a ... ,The authors state that discrepancy could be due to ... ,Cerebrovascular events are frequently accompanied by characteristic neurological deficits, ... occurs. People with events on the left side of ...
... marketed as functional food ingredients, or even synthesized for use ... able to identify the molecular structure of flavonols found in ... They also say that they are able to synthesize not ... specific needs. , ,Several studies in recent years have ...
Cached Medicine News:Health News:Malignant Mesothelioma – A New Genetic Revelatio 2Health News:Malignant Mesothelioma – A New Genetic Revelatio 3Health News:"Defeat AIDS Pledge" by Andhra CM 2Health News:Stroke In The Right-Brain Can Remain Undiagnosed 2
(Date:3/5/2015)... , March 5, 2015  Relmada Therapeutics, Inc. ... for the treatment of chronic pain, today announced ... to advisory roles. The panel of experts will ... and efforts to advance the company pipeline of ... bring expertise in a range of areas including ...
(Date:3/5/2015)...  Celsion Corporation (NASDAQ: CLSN ) ... conference call to discuss year-end 2014 financial results ... for ThermoDox®, its proprietary heat-activated liposomal encapsulation of ... and TheraSilence™, in immunotherapy and RNA delivery at ... To participate in the call, interested parties may ...
(Date:3/5/2015)... -- LUNGevity Foundation, the nation,s leading lung cancer ... approval of Bristol Myers Squibb,s new immunotherapy drug ... another critical new treatment option to fight lung ... own immune system to fight cancerous cells. Importantly, ... with squamous cell lung cancer, a population for ...
Breaking Medicine Technology:Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 2Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 3Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 4Celsion Corporation to Hold Year-End 2014 Financial Results Conference Call on Thursday, March 12, 2015 2LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 2LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 3
... DURHAM, N.C., Sept. 16, 2011 Chimerix, Inc., ... today that investigators will present preliminary data for ... Annual Interscience Conference on Antimicrobial Agents and Chemotherapy ... Genovefa Papanicolaou, M.D., Associate Member of Infectious Diseases ...
... 2011 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: ... of medical devices worldwide, today announced the introduction of ... States. The black and white portable unit provides outstanding ... for use in numerous specialty markets. With DP-50,s launch, ...
Cached Medicine Technology:Chimerix Announces Late-Breaker Presentation at 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Annual Meeting 2Chimerix Announces Late-Breaker Presentation at 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Annual Meeting 3Mindray Introduces DP-50 Portable Ultrasound System in the U.S. 2Mindray Introduces DP-50 Portable Ultrasound System in the U.S. 3
Escherichia coli - For the qualitative detection of Escherichia coli 0157 and 0157:H7 in food products. Accessories BinaxNOW EH E.coli 0157 & 0157:H7 Control Swab Pack (510-000), BinaxNow E.coli...
... For the qualitative differential ... (P.f) antigen and an antigen ... four species of malaria:plasmodium falciparum ... ovale (P.o) and Plasmodium malariae ...
For the qualitative detection of antibodies to HIV-1 and HIV-2 in human serum, plasma and whole blood specimens...
For the qualitative detection of antibodies to HIV-1 and HIV-2 in human serum, plasma and whole blood specimens...
Medicine Products: